Literature DB >> 18852231

Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study.

C R L Cardoso1, F V Signorelli, J A S Papi, G F Salles.   

Abstract

The aim of this study was to investigate whether initial and accrued organ damage measured by Systemic Lupus International Collaborating Clinics (SLICC) Damage Index (SDI) predicts mortality in cohort of Brazilian patients with systemic lupus erythematosus (SLE). One hundred and five outpatients with SLE were enrolled from July 2000 to March 2001; their demographics, disease manifestations, interventions and quantified disease activity (SLEDAI) were obtained. SDI was measured at baseline and at the end of follow-up. Initial and accrued SDI prognostic values for mortality were investigated by multivariate Cox survival analysis and Kaplan-Meyer survival curves. After a median follow-up of 6.3 years, 19 patients died due to disease activity, end-organ failure, cardiovascular events, cancer and infection. Deceased patients had longer disease duration and greater initial and final SDI than survivors had. After adjustment for age, sex and disease duration, both initial and final SDI >/= 3 points were independent predictors of mortality, with hazard ratios (HRs) of 3.0 (1.1-8.2) and 4.7 (1.6-14.5), respectively. Damage accrual during follow-up was the strongest predictor of death (HR: 5.1, 2.0-13.0). Renal and pulmonary damages were the main predictors of increased mortality risk. In conclusion, baseline and accrued damage increase mortality risk in Brazilian patients with SLE. Measures to prevent damage development and progression are urgent to reduce the mortality of patients with SLE.

Entities:  

Mesh:

Year:  2008        PMID: 18852231     DOI: 10.1177/0961203308093829

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  19 in total

1.  Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.

Authors:  Alexandra Legge; Susan Kirkland; Kenneth Rockwood; Pantelis Andreou; Sang-Cheol Bae; Caroline Gordon; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Daniel J Wallace; Sasha Bernatsky; Ann E Clarke; Joan T Merrill; Ellen M Ginzler; Paul Fortin; Dafna D Gladman; Murray B Urowitz; Ian N Bruce; David A Isenberg; Anisur Rahman; Graciela S Alarcón; Michelle Petri; Munther A Khamashta; M A Dooley; Rosalind Ramsey-Goldman; Susan Manzi; Kristjan Steinsson; Asad A Zoma; Cynthia Aranow; Meggan Mackay; Guillermo Ruiz-Irastorza; S Sam Lim; Murat Inanc; Ronald F van Vollenhoven; Andreas Jonsen; Ola Nived; Manuel Ramos-Casals; Diane L Kamen; Kenneth C Kalunian; Soren Jacobsen; Christine A Peschken; Anca Askanase; John G Hanly
Journal:  Arthritis Rheumatol       Date:  2019-05-29       Impact factor: 10.995

2.  Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.

Authors:  Jordana Vaz Hendler; Lucian de Souza; Daniele Corrêa de Freitas Zernow; Juliano Guimarães; Thiago Bertotto; Carla Forgiarini Saldanha; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2017-06-26       Impact factor: 2.980

3.  Causes and predictors of death in Brazilian lupus patients.

Authors:  Rosa Weiss Telles; Cristina Costa Duarte Lanna; Fabiana Lemos Souza; Luciana Andrade Rodrigues; Rodrigo Citton Padilha Reis; Antonio Luiz Ribeiro
Journal:  Rheumatol Int       Date:  2012-03-30       Impact factor: 2.631

4.  Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus.

Authors:  Jinoos Yazdany; Laura Trupin; Stuart A Gansky; Maria Dall'era; Edward H Yelin; Lindsey A Criswell; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

Review 5.  The socioeconomic burden of SLE.

Authors:  Chak Sing Lau; Anselm Mak
Journal:  Nat Rev Rheumatol       Date:  2009-06-09       Impact factor: 20.543

Review 6.  Organ Damage and Quality of Life in Antiphospholipid Syndrome.

Authors:  P Alba; J A Gómez-Puerta; M V Goycochea-Robles; M C Amigo
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

7.  Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.

Authors:  M Frodlund; A Vikerfors; G Grosso; T Skogh; J Wetterö; K Elvin; I Gunnarsson; A Kastbom; Ö Dahlström; J Rönnelid; E Svenungsson; C Sjöwall
Journal:  Clin Exp Immunol       Date:  2018-09-12       Impact factor: 4.330

8.  Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort.

Authors:  C Drenkard; J Yazdany; L Trupin; P P Katz; C Dunlop-Thomas; G Bao; S S Lim
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-06       Impact factor: 4.794

9.  Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus.

Authors:  Zahra Sayed Bonakdar; Negin Mohtasham; Mansoor Karimifar
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

10.  Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.

Authors:  Alexandra Legge; Susan Kirkland; Kenneth Rockwood; Pantelis Andreou; Sang-Cheol Bae; Caroline Gordon; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Daniel J Wallace; Sasha Bernatsky; Ann E Clarke; Joan T Merrill; Ellen M Ginzler; Paul R Fortin; Dafna D Gladman; Murray B Urowitz; Ian N Bruce; David A Isenberg; Anisur Rahman; Graciela S Alarcón; Michelle Petri; Munther A Khamashta; M A Dooley; Rosalind Ramsey-Goldman; Susan Manzi; Asad A Zoma; Cynthia Aranow; Meggan Mackay; Guillermo Ruiz-Irastorza; S Sam Lim; Murat Inanc; Ronald F van Vollenhoven; Andreas Jonsen; Ola Nived; Manuel Ramos-Casals; Diane L Kamen; Kenneth C Kalunian; Soren Jacobsen; Christine A Peschken; Anca Askanase; John G Hanly
Journal:  Arthritis Rheumatol       Date:  2020-02-12       Impact factor: 15.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.